BMJ Best Practice

参考文献

关键文献

Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985 Jan;121(1):31-6.

Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003 Mar;142(3):268-72.

Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000 Oct;232(4):508-14.

Knott-Craig CJ, Elkins RC, Lane MM, et al. A 26-year experience with surgical management of tetralogy of Fallot: risk analysis for mortality or late reintervention. Ann Thorac Surg. 1998 Aug;66(2):506-11.

Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-3128.

Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81.

Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57.

参考文章

1.  Allen HD, Driscoll DJ, Shaddy RE, et al. Moss and Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.

2.  Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985 Jan;121(1):31-6.

3.  Gill H, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease: an analysis of 6640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol. 2003 Sep 3;42(5):923-9.

4.  Garne E, Nielsen G, Hansen OK, et al. Tetralogy of Fallot: a population-based study of epidemiology, associated malformations and survival in western Denmark 1984-1992. Scand Cardiovasc J. 1999;33(1):45-8.

5.  Grech V. An excess of tetralogy of Fallot in Malta. J Epidemiol Community Health. 1998 May;52(5):280-82.

6.  Ferencz C, Correa-Villasenor A, Loffredo CA, et al. Malformations of the cardiac outflow tract. In: Ferencz C, Correa-Villasenor A, Loffredo CA, et al, eds. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study: 1981-1989. Armonk, NY: Futura Publishing Co Inc; 1997:59-102.

7.  Kessler-Icekson G, Birk E, Weintraub AY, et al. Association of tetralogy of Fallot with a distinct region of del22q11.2. Am J Med Genet. 2002 Feb 1;107(4):294-8.

8.  Momma K, Kondo C, Ando M, et al. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol. 1995 Sep 15;76(8):618-21.

9.  Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997 Jul;16(3):243-51.

10.  Krantz ID, Smith R, Colliton RP, et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet. 1999 May 7;84(1):56-60.

11.  Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation. 2001 Nov 20;104(21):2565-8.

12.  Vrijheid M, Martinez D, Manzanares S, et al. Ambient air pollution and risk of congenital anomalies: a systematic review and meta-analysis. Environ Health Perspect. 2011 May;119(5):598-606.

13.  Koch R, Levy HL, Matalon R, et al. The North American Collaborative Study of Maternal Phenylketonuria. Status report 1993. Am J Dis Child. 1993 Nov;147(11):1224-30.

14.  Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837-41.

15.  Feldman GL, Weaver DD, Lovrien EW. The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Am J Dis Child. 1977 Dec;131(12):1389-92.

16.  Kothari SS. Mechanism of cyanotic spells in tetralogy of Fallot - the missing link? Int J Cardiol. 1992 Oct;37(1):1-5.

17.  Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003 Mar;142(3):268-72.

18.  Rosati E, Chitano G, Dipaola L, et al. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med. 2005;33(5):455-7.

19.  Dabizzi R, Teodori G, Barletta GA, et al. Associated coronary and cardiac anomalies in the tetralogy of Fallot. An angiographic study. Eur Heart J. 1990 Aug;11(8):692-704.

20.  Kambe T, Kato T, Hibi N, et al. Differential diagnosis of pulmonary stenosis by means of intracardiac phonocardiography. Jpn Heart J. 1976 Nov;17(6):691-705.

21.  Martin GR, Beekman RH 3rd, Mikula EB, et al. Implementing recommended screening for critical congenital heart disease. Pediatrics. 2013 Jul;132(1):e185-92.

22.  Yuan SM, Shinfeld A, Raanani E. The Blalock-Taussig shunt. J Card Surg. 2009 Mar-Apr;24(2):101-8.

23.  Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate: results in the modern era. Ann Surg. 2000 Oct;232(4):508-14.

24.  Parry AJ, McElhinney DB, Kung GC, et al. Elective primary repair of acyanotic tetralogy of Fallot in early infancy: overall outcome and impact on the pulmonary valve. J Am Coll Cardiol. 2000 Dec;36(7):2279-83.

25.  Saxena A, Ramakrishnan S, Tandon R, et al; Working Group on Management of Congenital Heart Diseases in India. Consensus on timing of intervention for common congenital heart diseases. Indian Pediatr. 2008 Feb;45(2):117-26.

26.  Knott-Craig CJ, Elkins RC, Lane MM, et al. A 26-year experience with surgical management of tetralogy of Fallot: risk analysis for mortality or late reintervention. Ann Thorac Surg. 1998 Aug;66(2):506-11.

27.  Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007 Jul 31;116(5):545-51.

28.  Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005 Mar 15;95(6):779-82.

29.  Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006:11-22.

30.  Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075-3128.

31.  Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005 Aug 23;112(8):1189-97.

32.  Abbott ME. Atlas of congenital cardiac disease. New York, NY: American Heart Association; 1936.

33.  Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997 Nov 1;30(5):1374-83.

34.  Nollert G, Däbritz SH, Schmoeckel M, et al. Risk factors for sudden death after repair of tetralogy of Fallot. Ann Thorac Surg. 2003 Dec;76(6):1901-5.

35.  Silka M, Hardy BG, Menashe VD, et al. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998 Jul;32(1):245-51.

36.  Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81.

37.  Daliento L, Rizzoli G, Menti L, et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart. 1999 Jun;81(6):650-55.

38.  Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995 Jul 15;92(2):231-7.

39.  Roos-Hesselink J, Perlroth MG, McGhie J, et al. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation. 1995 Apr 15;91(8):2214-9.

40.  Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004 Mar 17;43(6):1068-74.

41.  Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. Circulation. 2008 Dec 2;118(23):e714-833.

42.  Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010 Dec;31(23):2915-57.

43.  Canobbio MM, Warnes CA, Aboulhosn J, et al; American Heart Association. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017 Feb 21;135(8):e50-87.

44.  American College of Radiology. ACR Appropriateness Criteria® known or suspected congenital heart disease in the adult. Jun 2016 [internet publication].

45.  Valente AM, Cook S, Festa P, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American Society of Echocardiography: developed in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society for Pediatric Radiology. J Am Soc Echocardiogr. 2014 Feb;27(2):111-41.

46.  Siu SC, Colman JM. Heart disease and pregnancy. Heart. 2001 Jun;85(6):710-15.

使用此内容应接受我们的免责声明